Abstract
Antibody epitope mapping is crucial for understanding B cell-mediated immunity and required for characterizing therapeutic antibodies. In contrast to T cell epitope mapping, no computational tools are in widespread use for prediction of B cell epitopes. Here, we show that, utilizing the sequence of an antibody, it is possible to identify discontinuous epitopes on its cognate antigen. The predictions are based on residue-pairing preferences and other interface characteristics. We combined these antibody-specific predictions with results of cross-blocking experiments that identify groups of antibodies with overlapping epitopes to improve the predictions. We validate the high performance of this approach by mapping the epitopes of a set of antibodies against the previously uncharacterized D8 antigen, using complementary techniques to reduce method-specific biases (X-ray crystallography, peptide ELISA, deuterium exchange, and site-directed mutagenesis). These results suggest that antibody-specific computational predictions and simple cross-blocking experiments allow for accurate prediction of residues in conformational B cell epitopes.
Original language | English |
---|---|
Pages (from-to) | 646-657 |
Number of pages | 12 |
Journal | Structure |
Volume | 22 |
Issue number | 4 |
DOIs | |
State | Published - 8 Apr 2014 |
Bibliographical note
Funding Information:This project has been funded in whole or in part with federal funds from the National Institutes of Allergy and Infectious Diseases under Contract no. HHSN272200900048C. Y.O. was supported in part by the Israeli Science Foundation, grant no. 511/10 ( http://www.isf.org.il ). We thank Anat Burkovitz for providing the data set; Shauli Ashkenazy for running the ISIS and MD programs; and Ariel Feiglin, Vered Kunik, Sivan Goren, and Ahron Brodie for their helpful comments.
Funding
This project has been funded in whole or in part with federal funds from the National Institutes of Allergy and Infectious Diseases under Contract no. HHSN272200900048C. Y.O. was supported in part by the Israeli Science Foundation, grant no. 511/10 ( http://www.isf.org.il ). We thank Anat Burkovitz for providing the data set; Shauli Ashkenazy for running the ISIS and MD programs; and Ariel Feiglin, Vered Kunik, Sivan Goren, and Ahron Brodie for their helpful comments.
Funders | Funder number |
---|---|
National Institute of Allergy and Infectious Diseases | HHSN272200900048C |
Israel Science Foundation | 511/10 |